Oral Manifestations of Chronic Inflammatory Bowel Diseases: A Survey of IBD Patients in the Gastroenterology and Hepatology Department at IBN ROCHD University Hospital in Casablanca
Chronic inflammatory bowel diseases (IBD), encompassing Crohn’s disease (CD) and ulcerative colitis (UC), are characterized by persistent gastrointestinal inflammation influenced by genetic, immunological, and environmental factors. These conditions frequently affect young adults and are often associated with oral manifestations that significantly impact patients’ quality of life. This cross-sectional descriptive study investigates the prevalence and nature of oral manifestations in IBD patients treated at the Gastroenterology and Hepatology Department of IBN ROCHD University Hospital in Casablanca, emphasizing the importance of integrating oral health care into comprehensive IBD management. The study included 90 patients, of whom 52.2% were women and 54.4% were under 40 years old. CD was the predominant diagnosis (71%). A total of 73.3% of patients reported oral health issues since their IBD diagnosis, with inflammation (51.5%), ulcers (24.2%), and aphthous lesions (16.7%) being the most common complaints. Clinical examinations revealed poor oral hygiene in 62.2% of patients, and 64.6% reported dry mouth. Observed oral lesions included erythema (55.6%), hyperplasia (36.7%), candidiasis (32.2%), and ulcers (20%). Regarding treatments, 60% of patients were on immunosuppressants, 23.3% on salicylates, and 21.1% on corticosteroids. The findings align with prior epidemiological studies, confirming a slight female predominance and a high prevalence in young adults. Oral complications such as ulcers, aphthous lesions, periodontal issues, and dry mouth are common and necessitate vigilant monitoring. A multidisciplinary approach, including collaboration between gastroenterologists and dental professionals, is essential for optimal patient care. This study underscores the critical need for regular oral health assessments and preventive interventions to mitigate oral complications and improve the overall quality of life for patients with IBD.
Cite this paper
Nabli, M. , Badre, W. , Fariri, J. and Badre, B. (2025). Oral Manifestations of Chronic Inflammatory Bowel Diseases: A Survey of IBD Patients in the Gastroenterology and Hepatology Department at IBN ROCHD University Hospital in Casablanca. Open Access Library Journal, 12, e2826. doi: http://dx.doi.org/10.4236/oalib.1112826.
Loddo, I. and Romano, C. (2015) Inflammatory Bowel Disease: Genetics, Epige-netics, and Pathogenesis. Frontiers in Immunology, 6, Article 551. https://doi.org/10.3389/fimmu.2015.00551
Burisch, J. and Munkholm, P. (2015) The Epidemiology of Inflammatory Bowel Disease. Scandinavian Journal of Gastroenterology, 50, 942-951. https://doi.org/10.3109/00365521.2015.1014407
Juillerat, P., Pittet, V., Bulliard, J., Guessous, I., Antonino, A.T., Mottet, C., et al. (2008) Prevalence of Inflammatory Bowel Disease in the Canton of Vaud (Switzerland): A Popula-tion-Based Cohort Study. Journal of Crohn’s and Colitis, 2, 131-141. https://doi.org/10.1016/j.crohns.2007.10.006
Cao, L., Dayimu, A., Guan, X., Duan, M., Zeng, S., Wang, H., et al. (2024) Global Evolving Patterns and Cross-Country Inequalities of Inflammatory Bowel Disease Burden from 1990 to 2019: A Worldwide Report. Inflammation Research, 73, 277-287. https://doi.org/10.1007/s00011-023-01836-7
Jansen, F.M., Vavricka, S.R., den Broeder, A.A., de Jong, E.M., Hoentjen, F. and van Dop, W.A. (2020) Clinical Management of the Most Common Extra‐Intestinal Manifestations in Pa-tients with Inflammatory Bowel Disease Focused on the Joints, Skin and Eyes. United European Gastroenterology Journal, 8, 1031-1044. https://doi.org/10.1177/2050640620958902
Karamanolis, G.P. (2006) Cutaneous and Ocular Manifestations of IBD. Annals of Gastroenterology, 19, 181-183. http://www.annalsgastro.gr/index.php/annalsgastro/article/view/423
Migliorisi, G., Vella, G., Dal Buono, A., Gabbiadini, R., Busacca, A., Loy, L., et al. (2024) Ophthalmological Manifestations in Inflammatory Bowel Diseases: Keep an Eye on It. Cells, 13, Article 142. https://doi.org/10.3390/cells13020142
Lamb, C.A., Kennedy, N.A., Raine, T., Hendy, P.A., Smith, P.J., Limdi, J.K., et al. (2019) British Society of Gastroenterology Consensus Guidelines on the Management of Inflammatory Bowel Disease in Adults. Gut, 68, s1-s106. https://doi.org/10.1136/gutjnl-2019-318484
Mowat, C., Cole, A., Wind-sor, A., Ahmad, T., Arnott, I., Driscoll, R., et al. (2011) Guidelines for the Man-agement of Inflammatory Bowel Disease in Adults. Gut, 60, 571-607. https://doi.org/10.1136/gut.2010.224154
Im, J.P., Ye, B.D., Kim, Y.S. and Kim, J.S. (2018) Changing Treatment Paradigms for the Management of Inflammatory Bowel Disease. The Korean Journal of Internal Medicine, 33, 28-35. https://doi.org/10.3904/kjim.2017.400
Cai, Z., Wang, S. and Li, J. (2021) Treatment of Inflammatory Bowel Disease: A Comprehensive Review. Frontiers in Medicine, 8, Article 765474. https://doi.org/10.3389/fmed.2021.765474
Lee, J., Pedretti, C. and Konijeti, G. (2019) Clinical Course and Dietary Patterns among Patients Incor-porating the Autoimmune Protocol for Management of Inflammatory Bowel Disease (p12-010-19). Current Developments in Nutrition, 3, nzz035.P12-010-19. https://doi.org/10.1093/cdn/nzz035.p12-010-19
Sack, C., Phan, V.A., Grafton, R., Holtmann, G., van Langenberg, D.R., Brett, K., et al. (2012) A Chronic Care Model Significantly Decreases Costs and Healthcare Utilisation in Patients with Inflammatory Bowel Disease. Journal of Crohn’s and Colitis, 6, 302-310. https://doi.org/10.1016/j.crohns.2011.08.019
Nguyen, G.C., Seow, C.H., Maxwell, C., Huang, V., Leung, Y., Jones, J., et al. (2016) The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy. Gastroenterology, 150, 734-757.e1. https://doi.org/10.1053/j.gastro.2015.12.003
Lauritano, D., Boccalari, E., Di Stasio, D., Della Vella, F., Carinci, F., Lucchese, A., et al. (2019) Prevalence of Oral Lesions and Correlation with Intestinal Symptoms of Inflammatory Bow-el Disease: A Systematic Review. Diagnostics, 9, Article 77. https://doi.org/10.3390/diagnostics9030077
Enchev, M. and Georgieva, G. (2021) Dental Health in Patients with Inflammatory Bowel Disease and the Role of Biomarkers in Diagnosis. Varna Medical Forum, 10, 232-236. https://doi.org/10.14748/vmf.v10i2.7907
Lima Martins, A., Volpato, R.A. and Zago-Gomes, M.D.P. (2018) The Prevalence and Phenotype in Brazilian Patients with Inflammatory Bowel Disease. BMC Gastroenterology, 18, Article No. 87. https://doi.org/10.1186/s12876-018-0822-y
Fukunaga, S., Kuwaki, K., Mitsuyama, K., Takedatsu, H., Yoshioka, S., Yamasaki, H., et al. (2017) Detection of Calprotectin in Inflammatory Bowel Disease: Fecal and Serum Levels and Immunohistochemical Localization. International Journal of Molecular Medicine, 41, 107-118. https://doi.org/10.3892/ijmm.2017.3244
Huguet, J.M., Iborra, M., Bosca-Watts, M.M., Maroto, N., Gil, R., Cortes, X., et al. (2018) In-flammatory Bowel Disease in Patients over the Age of 70 Y. Does the Disease Duration Influence Its Behavior? Scandinavian Journal of Gastroenterology, 53, 1079-1084. https://doi.org/10.1080/00365521.2018.1501603
Kappelman, M.D., Rifas-Shiman, S.L., Kleinman, K., Ollendorf, D., Bousvaros, A., Grand, R.J., et al. (2007) The Prevalence and Geographic Distribution of Crohn’s Disease and Ul-cerative Colitis in the United States. Clinical Gastroenterology and Hepatology, 5, 1424-1429. https://doi.org/10.1016/j.cgh.2007.07.012
Asakura, K., Nishiwaki, Y., Inoue, N., Hibi, T., Watanabe, M. and Takebayashi, T. (2009) Prevalence of Ulcerative Colitis and Crohn’s Disease in Japan. Journal of Gas-troenterology, 44, 659-665. https://doi.org/10.1007/s00535-009-0057-3
Molinie, F. (2004) Oppo-site Evolution in Incidence of Crohn’s Disease and Ulcerative Colitis in Northern France (1988-1999). Gut, 53, 843-848. https://doi.org/10.1136/gut.2003.025346
Lankarani, K.B. (2013) Oral Manifestation in Inflammatory Bowel Disease: A Review. World Journal of Gas-troenterology, 19, 8571-8579. https://doi.org/10.3748/wjg.v19.i46.8571
Khozeimeh, F., Shakerin, H., Daghaghzadeh, H., Najarzadegan, F., Golestannejad, Z. and Adibi, P. (2021) Oral Manifestations in Inflammatory Bowel Disease: A Cross-Sectional Study in Isfahan. Dental Research Journal, 18, 4. https://doi.org/10.4103/1735-3327.310033
Basu, M.K. (1976) Oral Manifestations of Crohn’s Disease: Studies in the Pathogenesis. Proceedings of the Royal Society of Medicine, 69, 765-766. https://doi.org/10.1177/003591577606901019
Michailidou, E., Ar-vanitidou, S., Lombardi, T., Kolokotronis, A., Antoniades, D. and Samson, J. (2009) Oral Lesions Leading to the Diagnosis of Crohn Disease: Report on 5 Pa-tients. Quintessence International, 40, 581-588.
Cherbi, S. and Wierzba, C. (2009) Manifestations buccales des maladies systémiques: La maladie de Crohn et la rectocolite hémorragique. Actualités Odonto-Stomatologiques, 246, 113-127. https://doi.org/10.1051/aos/2009002
Flemmig, T.F., Sha-nahan, F. and Miyasaki, K.T. (1991) Prevalence and Severity of Periodontal Disease in Patients with Inflammatory Bowel Disease. Journal of Clinical Perio-dontology, 18, 690-697. https://doi.org/10.1111/j.1600-051x.1991.tb00111.x
Habashneh, R.A., Khader, Y.S., Alhumouz, M.K., Jadallah, K. and Ajlouni, Y. (2011) The Associa-tion between Inflammatory Bowel Disease and Periodontitis among Jordanians: A Case-Control Study. Journal of Periodontal Research, 47, 293-298. https://doi.org/10.1111/j.1600-0765.2011.01431.x
Woo, V., Herschaft, E. and Wang, J. (2013) Oral Lesions as the Presenting Manifestation of Crohn Disease. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 116, e499. https://doi.org/10.1016/j.oooo.2013.09.039
Tan, C.X.W., Brand, H.S., de Boer, N.K.H. and Forouzanfar, T. (2016) Gastrointestinal Diseases and Their Oro-Dental Manifestations: Part 1: Crohn’s Disease. British Dental Journal, 221, 794-799. https://doi.org/10.1038/sj.bdj.2016.954
Brito, F., Barros, F.C.d., Zaltman, C., Pugas Carvalho, A.T., De Vasconcellos Carneiro, A.J., Fischer, R.G., et al. (2008) Prevalence of Periodontitis and DMFT Index in Pa-tients with Crohn’s Disease and Ulcerative Colitis. Journal of Clinical Periodon-tology, 35, 555-560. https://doi.org/10.1111/j.1600-051x.2008.01231.x
Aleksandra Nielsen, A., Nederby Nielsen, J., Schmedes, A., Brandslund, I. and Hey, H. (2005) Saliva Interleukin-6 in Patients with Inflammatory Bowel Disease. Scandinavian Jour-nal of Gastroenterology, 40, 1444-1448. https://doi.org/10.1080/00365520510023774
Renna, S. (2014) Opti-mization of the Treatment with Immunosuppressants and Biologics in Inflam-matory Bowel Disease. World Journal of Gastroenterology, 20, 9675-9690. https://doi.org/10.3748/wjg.v20.i29.9675
Nitzan, O. (2016) Role of Antibiotics for Treatment of Inflammatory Bowel Disease. World Journal of Gastroenterology, 22, 1078-1087. https://doi.org/10.3748/wjg.v22.i3.1078
